Safety and Efficacy of Turoctocog Alfa in Haemophilia A Subjects

NCT00840086 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Congenital Bleeding Disorder
Haemophilia A

Interventions

DRUG: turoctocog alfa

Sponsor

Novo Nordisk A/S